These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 263851)

  • 1. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Gross MD
    Pediatrics; 1976 Sep; 58(3):423-31. PubMed ID: 958770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
    Dillon DC; Salzman IJ; Schulsinger DA
    J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth disturbances in hyperkinetic children.
    Greenhill LL; Puig-Antich J; Halpern F; Sachar EJ; Rubinstein B; Chambers W; Fiscina B; Florea J
    Pediatrics; 1980 Jul; 66(1):152-4. PubMed ID: 7402783
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of stimulant medication on the growth of hyperkinetic children.
    Roche AF; Lipman RS; Overall JE; Hung W
    Pediatrics; 1979 Jun; 63(6):847-50. PubMed ID: 450520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonidine for stimulant-related sleep problems.
    Rubinstein S; Silver LB; Licamele WL
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):281-2. PubMed ID: 8150803
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication compliance in hyperactive children.
    Kauffman RE; Smith-Wright D; Reese CA; Simpson R; Jones F
    Pediatr Pharmacol (New York); 1981; 1(3):231-7. PubMed ID: 7346742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyperkinetic child: current status.
    Dubey DR
    Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD; Carlson GA; Kelly KL; Pataki C
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):333-42. PubMed ID: 8444762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic issues in the syndrome of minimal brain dysfunction.
    Omenn GS
    Semin Psychiatry; 1973 Feb; 5(1):5-17. PubMed ID: 4610759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.